JCCC Research Seminar Featuring Dr. Guido Eibl
Obesity, Inflammation and Pancreatic Cancer
12:00 PM - 1:00 PM
10833 Le Conte Ave.
Los Angeles, California 90095
Guido Eibl, M.D.
Associate Professor, Department of Surgery
Director of Surgical Research, Division of General Surgery
Director, NCI Program Project on Diet-Induced Pancreatic Cancer
Member of the Signal Transduction and Therapeutics Program Area
Dr. Guido Eibl studies the role of cyclooxygenase enzymes in pancreatic cancer. Cyclooxygenases convert certain fatty acids to biologically active products called prostaglandins, which have a variety of effects on cancer cells. They can stimulate pancreatic cancer growth and spread and increase the resistance to chemotherapeutic agents. Inhibiting the production of prostaglandins is therefore a promising therapeutic approach in pancreatic cancer.
Light lunch served
Sponsored by the JCCC Signal Transduction and Therapeutics Program Area